Ocular Therapeutix Inc (OCUL)

R&D Expense Growth

-18.24%

Quarterly · Period ending:

OCUL logo

OCUL R&D Expense Growth

Latest reported-18.24%
OCUL Quarterly R&D Growth (QoQ) (0.00% → -18.24%)
High-resolution chart · PNG

OCUL r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ocular Therapeutix Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-18.2366%
30.3406%
-2.9757%
2.5%
19.1894%
4.5573%
10.6196%
28.4056%
39.1705%
28.0333%
7.8301%
-0.4969%
2.353%
8.8902%
-1.2829%
4.7252%
0%
4.1501%
-1.1086%
-8.2257%
26.8326%
43.3237%
9.6821%
-13.34%
31.5349%
-39.7728%
-1.0747%
8.7211%
-16.8154%
10.3236%
5.9164%
10.749%
6.2963%
4.0339%
-2.6827%
0.1109%
20.6271%
-8.1741%
28.8779%
-18.5153%
-1.3431%
2.7157%
-16.6646%
22.5419%
42.8904%
-8.3333%
14.8594%
4.4268%
-13.4328%
74.4546%
2.0833%
15.807%
-3.3374%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.